Skip to main content

Biosyent Inc (RX-X) Quote

Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 5.850
Day High 6.000
Open:6.000
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

BioSyent Schedules Q3 and YTD 2019 Earnings Release for November 20, 2019
- GlobeNewswire - Tue Nov 12, 7:00AM CST
GlobeNewswire - CMTX
Tue Nov 12, 7:00AM CST
BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2019 on Wednesday, November 20, 2019. A presentation on the Company's third quarter and year-to-date 2019 results by Rene Goehrum, BioSyent President and CEO, will also be available on the Company's website on the date of release.
BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Seventh Consecutive Year
- GlobeNewswire - Thu Sep 12, 8:00AM CDT
GlobeNewswire - CMTX
Thu Sep 12, 8:00AM CDT
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it has been named to the 31st annual Growth 500 ranking of Canada's Fastest-Growing Companies by Canadian Business and Maclean's. The Growth 500 ranks Canada's top private and public companies based on five-year revenue growth. Results of the annual ranking are published in a special report in Maclean's magazine and online at CanadianBusiness.com.
BioSyent Releases Q2 and H1 2019 Results
- GlobeNewswire - Fri Aug 23, 7:00AM CDT
GlobeNewswire - CMTX
Fri Aug 23, 7:00AM CDT
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2019. Key highlights include:
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 5.510 +6.17% increase
on 10/28/19
Period Open:5.800
Price movement based on the high, low and last over the given period.
6.250 -6.40% decrease
on 10/30/19
+0.050 (+0.86%) increase
since 10/17/19
3-Month 5.510 +6.17% increase
on 10/28/19
Period Open:6.290
Price movement based on the high, low and last over the given period.
6.660 -12.16% decrease
on 08/22/19
-0.440 (-7.00%) decrease
since 08/16/19
52-Week 5.510 +6.17% increase
on 10/28/19
Period Open:8.600
Price movement based on the high, low and last over the given period.
8.880 -34.12% decrease
on 03/06/19
-2.750 (-31.98%) decrease
since 11/16/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).